Biologically Derived Hydrogen--Future Fuel?

Courtesy of Carla Santee  A NEW KIND OF BUBBLY: Suellen Van Ooteghem's bioreactor is producing a gas that is 80% hydrogen: "These results are unprecedented." A large glass bioreactor in the corner of Suellen Van Ooteghem's lab at the National Energy Technology Laboratory is filled with what appears to be murky champagne. The pale yellow solution even has tiny bubbles streaming to the top. The liquid is arguably as precious as any champagne, and the bubbles are even more valuable: They ar

Written bySam Jaffe
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

A large glass bioreactor in the corner of Suellen Van Ooteghem's lab at the National Energy Technology Laboratory is filled with what appears to be murky champagne. The pale yellow solution even has tiny bubbles streaming to the top. The liquid is arguably as precious as any champagne, and the bubbles are even more valuable: They are almost pure hydrogen.

Hydrogen, it's been said, is the fuel of the future. When used in fuel cells to create electricity, the only pollutant is water. But what prevents hydrogen from replacing oil as this country's main source of energy are a bundle of engineering hurdles. The greatest technological obstacle is the high cost of producing hydrogen cheaply and cleanly. The most promising current technology is the use of nuclear energy to heat water and blast natural gas with steam, stripping off the hydrogen ions--not exactly clean and green.

For decades, researchers had ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies